Authors
Robyn Loves, Donald B Kohn
Published in
Seminars in hematology. Sep 30, 2026. Epub Sep 30, 2026.
Abstract
Hematologic disorders variably affect red and white blood cells and platelets, resulting in diverse clinical manifestations including anemia, lysosomal storage disorders, or immune deficiency. Many of these conditions result from heritable monogenic mutations and can be definitively treated by healthy donor hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT, however, is limited by challenges of identifying suitable hematopoietic stem cell (HSC) donors, graft rejection, and graft-versus-host disease. As an alternative, transplantation of autologous gene-corrected HSCs circumvents many of these limitations and has enabled definitive treatment of dozens of patients with a wide range of hematologic disorders over the past 5 decades. This review summarizes the major milestones and ongoing developments in gene therapy to treat hematologic diseases.
PMID:
43057939
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0